Mechanisms of cardiotoxicity associated with ErbB2 inhibitors
Carmine Fedele(American Institutes for Research), Claudia De Lorenzo(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli), Giuseppe D’Alessio(Federico II University Hospital), Gennaro Riccio(Sapienza University of Rome), Angela Eliana Malara(Federico II University Hospital)
Cited by 74
Related Papers
Fish Waste: From Problem to Valuable Resource
|Marine Drugs|2021|568
Microalgae with Immunomodulatory Activities
|Marine Drugs|2019|184
Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C
|Cancer Discovery|2022|134
Ribonuclease/angiogenin inhibitor 1 regulates stress-induced subcellular localization of angiogenin and controls its growth and survival activities
|Journal of Cell Science|2013|112
Ranolazine Protects from Doxorubicin-Induced Oxidative Stress and Cardiac Dysfunction
|European Journal of Heart Failure|2014|92